ATOPIC DERMATITIS

This study compares two non-steroid ointments for treating eczema in Pakistani patients. Researchers want to see which cream works better at clearing skin and causes fewer side effects like burning or itching. The study will help doctors choose the best long-term treatment option…

This early-stage study aims to test the safety and side effects of an experimental injection called SKB575. It will involve 90 participants, including healthy adults and people with moderate-to-severe atopic dermatitis (eczema). Researchers will monitor how the body processes the…

This study is testing whether a 3-week treatment to reduce staph bacteria on the skin can help control eczema symptoms. Researchers will enroll 100 people with moderate-to-severe eczema to see if this bacterial reduction leads to less severe skin inflammation. Participants will u…

This study aims to find out which of two existing eczema creams works better for children with mild to moderate atopic dermatitis. It will involve 66 children aged 2 to 18, who will apply one of the creams twice a day for 28 days. Researchers will compare how well each cream clea…

This study is testing an injectable medication called MG-K10 for people aged 12 and older with moderate-to-severe atopic dermatitis (eczema) that hasn't improved enough with standard creams. The goal is to see if MG-K10 is safe and effective at reducing the itchy, inflamed skin r…

This study aims to see if a specific probiotic mixture can help control eczema in very young children. Researchers will give the probiotic or a placebo to 150 children aged 6 months to 3 years for 12 weeks. They will measure changes in skin severity, and see if the treatment redu…

This study is testing whether following a low-sodium diet can help improve the severity of eczema (atopic dermatitis). Researchers will have 40 adults follow a low-salt diet for 24 weeks and will also give them salt tablets or a placebo at different times to see how changing salt…

This study is testing whether an experimental injection called ADSTEM can help control moderate-to-severe atopic dermatitis (eczema) in adults. Researchers will compare ADSTEM against a placebo injection in 286 participants whose eczema hasn't responded well to standard treatment…

This study compares two moisturizing balms for treating mild to moderate atopic dermatitis (eczema) in children and adults. Researchers want to see if a new balm containing a patented seawater-derived ingredient works as well as the current most-prescribed balm. The trial will me…

This study is testing a new injectable antibody called SM17 for adults with moderate to severe atopic dermatitis (eczema) that doesn't respond well to standard creams. About 200 participants will receive either SM17 or a placebo shot to see if it safely reduces the severity of th…

This study aims to develop a new, non-invasive way to help diagnose inflammatory skin diseases like psoriasis and eczema. Researchers will take high-resolution photos of the eyes of about 950 people, including patients and healthy volunteers, to look for patterns. They will use c…

This study is testing whether leaving a newborn's natural waxy skin coating, called vernix, on after birth can help prevent eczema (atopic dermatitis) during the baby's first year. Over 1,300 mother-baby pairs will be randomly assigned to either delay the baby's first bath to let…

This study is testing a cream already sold in some countries to see how safe and effective it is for people with mild to moderate eczema (atopic dermatitis). It will include 105 adults and children, including those with darker skin tones, and follow them for 12 weeks. The main go…

This study is testing whether a non-steroidal moisturizing cream (URGO FilmoCream Eczema) helps improve eczema symptoms when used alongside a standard prescription steroid cream. Researchers will enroll 44 adults with atopic dermatitis who have two similar eczema patches. They wi…

This study aims to see if a daily probiotic supplement can help manage common infant problems like colic, constipation, diarrhea, reflux, and eczema. It will involve 140 babies aged 1 to 4 months, comparing the probiotic drops to a placebo for 25 days. Parents will track symptoms…

This study is testing a tiny device, about the size of a grain of rice, that is placed on the skin. The device contains tiny amounts of approved medications for eczema (atopic dermatitis) and psoriasis. Researchers aim to see if the device's local skin reaction can safely and eff…

This study will analyze existing medical records from 20,000 Italian patients with psoriasis, eczema, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers aim to understand how these conditions are treated in real-world practice and how patients' health evolves ove…

This study aims to understand the causes of eczema in babies by comparing skin fluid from healthy babies and those with the condition. Researchers will use a gentle, non-invasive device to painlessly collect tiny fluid samples from the skin of 30 babies. The goal is to identify c…

This study will follow 50 Costa Rican patients with moderate-to-severe eczema who are already receiving advanced treatments like dupilumab or JAK inhibitors. Researchers will track how their skin condition and quality of life change over time during routine medical care. The goal…

This study aims to understand how caring for a child with mild to moderate eczema affects caregivers' daily lives. Researchers will survey 100 Canadian caregivers about their work productivity, family activities, and emotional well-being. The goal is to gather real-world data to …

This early-stage study aims to understand how different injection devices affect how the body absorbs SHR-1819, a potential treatment for atopic dermatitis (eczema). Researchers will enroll 160 healthy volunteers to compare the drug's absorption and safety when delivered through …